No, 32-cents to 2-cents would be sharp. But you should know that the PPS alone should not be the only reason to invest in ELTP. Much of the perceived value in its potential ELI product line and other generics should not underestimated. As a shareholder, my only concerns are seeing the actual results financially. We have a positive cash flow machine over here at work.